Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT06353334

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Tang Ziren (from the registry)
Registry
  • NCT NCT06353334
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06353334. Randomized; quadruple masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)
Condition
Butylphthalide
Condition
Neuroprotective Drugs
Intervention (Drug)
Butylphthalide and Sodium Chloride Injection
Intervention (Drug)
Saline Solution
Lead sponsor
Tang Ziren (class: other)

Record details

Record id
cardio:ct-nct06353334
Content hash
69b3e0f84f26ebb018a5cf681f6cb7646775df16849c2c33c81d7f3f42f32bdb